RT Journal Article
SR Electronic
T1 Mutations in EPG5 are associated with a wide spectrum of neurodevelopmental and neurodegenerative disorders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.12.24308722
DO 10.1101/2024.06.12.24308722
A1 Dafsari, Hormos Salimi
A1 Deneubourg, Celine
A1 Singh, Kritarth
A1 Maroofian, Reza
A1 Suprenant, Zita
A1 Kho, Ay Lin
A1 Ingham, Neil J
A1 Steel, Karen P
A1 Sheshadri, Preethi
A1 Baur, Franciska
A1 Hentrich, Lea
A1 Gerisch, Birgit
A1 Zamani, Mina
A1 Alvares, Cesar
A1 Siddiqui, Ata
A1 Dafsari, Haidar S
A1 Salari, Mehri
A1 Lang, Anthony
A1 Harris, Michael
A1 Abdelaleem, Alice
A1 Sadeghian, Saeid
A1 Azizimalamiri, Reza
A1 Galehdari, Hamid
A1 Shariati, Gholamreza
A1 Sedaghat, Alireza
A1 Zeighami, Jawaher
A1 Calame, Daniel
A1 Marafi, Dana
A1 Duan, Ruizhi
A1 Boehnke, Adrian
A1 Mohila, Carrie
A1 Steel, Dora
A1 Chopra, Saurabh
A1 Sharma, Suvasini
A1 Kohlschmidt, Nicolai
A1 Patzer, Steffi
A1 Saffari, Afshin
A1 Ebrahimi-Fakhari, Darius
A1 Eser Çavdartepe, Büşra
A1 Chang, Irene J
A1 Beckman, Erika
A1 Peters, Renate
A1 Fennell, Andrew Paul
A1 Lo, Bernice
A1 Averdunk, Luisa
A1 Distelmaier, Felix
A1 Baethmann, Martina
A1 Elmslie, Frances
A1 Joost, Kairit
A1 Nampoothiri, Sheela
A1 Yesodharan, Dhanya
A1 Mandel, Hannah
A1 Kimball, Amy
A1 Kline, Antonie D.
A1 Mignot, Cyril
A1 Keren, Boris
A1 Laugel, Vincent
A1 Õunap, Katrin
A1 Devadathan, Kalpana
A1 van Berkestijn, Frederique M.C.
A1 Silwal, Arpana
A1 Koene, Saskia
A1 Verma, Sumit
A1 Karim, Mohammed Yousuf
A1 Boubidi, Chahynez
A1 Aziz, Majid
A1 ElGhazali, Gehad
A1 Mattas, Lauren
A1 Miryounesi, Mohammad
A1 Hashemi-Gorji, Farzad
A1 Alavi, Shahryar
A1 Nouri, Nayereh
A1 Noruzinia, Mehrdad
A1 Kavousi, Saeedeh
A1 Kamath, Arveen
A1 Jayawant, Sandeep
A1 Saneto, Russell
A1 Haridy, Nourelhoda A.
A1 Kart, Pinar Ozkan
A1 Cansu, Ali
A1 Beneteau, Claire
A1 Stuurman, Kyra E.
A1 Wilke, Martina
A1 Barakat, Tahsin Stefan
A1 Tajsharghi, Homa
A1 Scardamaglia, Annarita
A1 Vallian, Sadeq
A1 Hız, Semra
A1 Shoeibi, Ali
A1 Boostani, Reza
A1 Hashemi, Narges
A1 Babaei, Meisam
A1 Alsaleh, Norah Saleh
A1 Lander, Julie
A1 Attié-Bitach, Tania
A1 Marzin, Pauline
A1 Wicher, Dorota
A1 Gold, Jessica I
A1 Monje, Mariana H G
A1 Krainc, Dimitri
A1 Mencacci, Niccolò
A1 Bakhtiari, Somayeh
A1 Kruer, Michael
A1 Argilli, Emanuela
A1 Sherr, Elliott
A1 Jamshidi, Yalda
A1 Karimiani, Ehsan Ghayoor
A1 Cheung, Yiu Wing Sunny
A1 Karin, Ivan
A1 Chung, Wendy K
A1 Lupski, James R.
A1 Kurian, Manju A.
A1 Dötsch, Jörg
A1 von Kleist-Retzow, Jürgen-Christoph
A1 Klopstock, Thomas
A1 Wagner, Matias
A1 Yip, Calvin
A1 Roos, Andreas
A1 Dionisi-Vici, Carlo
A1 Gautel, Mathias
A1 Duchen, Michael R
A1 Antebi, Adam
A1 Houlden, Henry
A1 Fanto, Manolis
A1 Jungbluth, Heinz
YR 2024
UL http://medrxiv.org/content/early/2024/06/13/2024.06.12.24308722.abstract
AB Autophagy is a fundamental and evolutionary conserved biological pathway with vital roles in intracellular quality control and homeostasis. The process of autophagy involves the engulfment of intracellular targets by autophagosomes and their delivery to the lysosome for digestion and recycling. We have previously reported recessive variants in EPG5, encoding for the ectopic P-granules 5 autophagy protein with a crucial role in autophagosome-lysosome fusion, as the cause of Vici syndrome (VS), a severe multisystem neurodevelopmental disorder defined by a combination of distinct clinical features including callosal agenesis, cataracts, cardiomyopathy, immunodeficiency, and hypopigmentation. Here, we present extensive novel genetic, clinical, neuroradiological and pathological features from the largest cohort of EPG5-related disorders reported to date, complemented by experimental findings from patient cells and models of EPG5 defects in Caenorhabditis elegans and Mus musculus. We identified 200 patients with recessive EPG5 variants, 86 of them previously unpublished. The associated phenotypic spectrum ranged from antenatally lethal presentations and the classic VS phenotype (n=60) to much milder neurodevelopmental disorders with less specific manifestations (n=140). Myopathic features and epilepsy with variable progression were frequently observed. Novel manifestations included early-onset parkinsonism and dystonia with cognitive decline during adolescence, hereditary spastic paraplegia (HSPP), and myoclonus. Radiological findings included previously recognized EPG5-related features with callosal abnormalities and pontocerebellar hypoplasia, and a range of novel features suggesting an emerging continuum with disorders of brain iron accumulation or copper metabolism as well as HSPPs. Genotype-phenotype studies suggested a correlation between predicted residual EPG5 expression and clinical severity, especially regarding disease progression and survival. The Epg5 p.Gln331Arg knock-in mouse, a model of milder EPG5-related disorders, showed an age-related motor phenotype and impaired autophagic clearance in several brain regions mirroring those also affected in humans. In Caenorhabditis elegans, epg-5 knockdown gave rise to neurodevelopmental features and motor impairment comparable to defects in parkinsonism-related genes, abnormal mitochondrial respiration, and impaired mitophagic clearance early in life. Cellular assays revealed impaired PINK1-Parkin dependent mitophagic clearance in patient fibroblasts. Our findings expand the phenotypic spectrum of EPG5-related disorders and indicate a life time continuum of disease that overlaps with other disorders of defective autophagy and intracellular trafficking. Our observations also suggest close links between early-onset neurodevelopmental and neurodegenerative conditions of later onset due to EPG5 defects, in particular dystonia and parkinsonism, highlighting the fundamental importance of dysfunctional autophagy in the pathophysiology of common neurodegenerative disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the European Union Horizon 2020 Programme (765912 DRIVE H2020-MSCA-ITN-2017) to CD, MF and HJ, Action Medical Research (2446) to HJ and MF, and Action Medical Research (GN2959) to KS and MRD. HSD was supported by the Koeln Fortune Program/Faculty of Medicine, University of Cologne (371/2021 and 243/2022), as well as the Cologne Clinician Scientist Program/Medical Faculty/University of Cologne and German Research Foundation (CCSP, DFG project No. 413543196). AA was supported by the Max Planck Gesellschaft. TSB was supported by the Netherlands Organisation for Scientific Research (ZonMw Vidi, grant 09150172110002), and acknowledges ongoing support from EpilepsieNL and CURE Epilepsy. KO is supported by Estonian Research Council grant PRG2040. Funding bodies did not have any influence on study design, results, and data interpretation or final manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Medical Faculty, University of Cologne gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.EPG5ectopic p granule protein 5VSVici syndromeMRImagnet resonance imaging